Abstract
As the global population ages, achieving a long and healthy life is becoming an increasingly important social issue. Since 1992, we have conducted the Tokyo Centenarians Study and, subsequently, the Japan semi-supercentenarians study to explore the biological, genetic, social, and environmental factors associated with healthy longevity. We have found a subset of centenarians who are independent in their activities of daily living and have a high probability of becoming supercentenarians (110 years or older). Identifying specific biomarkers conducive to healthy longevity in supercentenarians may provide insights into protective and/or delaying mechanisms against aging-related diseases. By using a unique dataset of 1427 elderly individuals, including 36 supercentenarians, 572 semi-supercentenarians (105–109 years), 288 centenarians (100–104 years), and 531 very old people (85–99 years), we found that N-terminal pro-B-type natriuretic peptide (NT-proBNP), interleukin-6, cystatin C, cholinesterase, and albumin were associated with all-cause mortality. Of these, low NT-proBNP levels were strongly associated with survival beyond 105 years, while albumin levels were associated with high mortality across all age groups. Results of single-cell RNA analyses showed that supercentenarians had an excess of cytotoxic CD4 T cells, which was unique to this exceptional population. In the near future, elucidation of the supercentenarian aging process by multi-omic approaches will provide valuable perspectives for developing translational clinical strategies for the prevention of age-related diseases and disabilities.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
1 Introduction
As the global population ages, achieving a long and healthy life is becoming an increasingly important social issue. In 1992, we started the Tokyo Centenarian Study (TCS) to explore the biological, genetic, and psychosocial factors associated with healthy longevity in centenarians (Gondo et al. 2006; Takayama et al. 2007). Many centenarians are independent in their activities of daily living (ADL) until their 90s. However, according to the TCS results, only about 20% of centenarians were independent at the age of 100 years or older, and the majority of centenarians needed some kind of assistance in their daily lives (Gondo et al. 2006). Subsequent follow-up studies have shown that centenarians who were physically independent had a high probability of becoming semi-supercentenarians (105 years or older) or even supercentenarians (110 years or older). In other words, ADL and survival are correlated in individuals well beyond the age of 100, and supercentenarians have an extremely long and healthy life expectancy. We started the Japan Semi-supercentenarian Study (JSS), a nationwide visiting survey, to recruit mainly those aged 105 years or older (Arai et al. 2014, 2015) to determine the genetic and biological factors of healthy longevity. Biomarkers generally refer to biological indicators that reflect the progress of a disease or the response to treatment and include biological substances such as proteins and genes contained in body fluids and tissues, such as blood and urine. The identification of specific biomarkers that faithfully reflect health indicators in supercentenarians will expand our knowledge on the biology of human longevity and improve the quality of medical care for age-related diseases and disabilities. In this chapter, we have summarized the previous and current findings on biomarkers for healthy longevity observed in the JSS.
2 Demography and Functional Status of Supercentenarians
Based on the increase in life expectancies over the recent decades, the world’s population of centenarians is growing rapidly. However, the total number of supercentenarians is extremely limited, and only few countries have reported on their exact status. According to the 2015 census, the total population in Japan is approximately 127 billion including 61,763 centenarians. Of the centenarians, 3916 are over 105 years old, and 146 are over 110 years old. The ratio of females to males is 6.36 among all centenarians, 8.99 among the supercentenarians, and 15.22 among the supercentenarians, indicating that the ratio of females increases with age. The ratio of centenarians to the total population is 1 per 2000 individuals, while the ratio is 1 per 32,000 individuals for the semi-supercentenarians and 1 per 870,000 individuals for supercentenarians. Even in Japan, a country with the highest number of the world’s oldest elderly, the presence of supercentenarians is extremely rare. Compared to the results of the 2010 census, the number of people aged 100 years and above increased by 129% in the 5 years leading up to 2015, the number of people aged 105 years and above increased by 153%, and the number of people aged 110 years and above increased by 187%. Further analysis of demographic trends is needed to conclude whether the supercentenarians represent the limit of human longevity or whether environmental factors such as the introduction of long-term care insurance are at play. Maintaining physical independence and cognitive function is a major component of healthy longevity. In the TCS and the JSS, we classified 642 centenarians, aged 100 years or above, into 3 groups according to the age at death: (1) 100–104 years old (centenarians), (2) 105–109 years old (semi-supercentenarians), and (3) 110 years old and above (supercentenarians) (Arai et al. 2014). The results showed that the supercentenarians had a higher ADL (Barthel Index) and cognitive function (mini-mental state examination, MMSE) than the semi-supercentenarians or centenarians when assessed at the age of 100–104 years (Arai et al. 2014). When the supercentenarians’ ADLs at age 105–109 were compared between the semi-supercentenarians and the centenarians, the Barthel Index was significantly higher in the supercentenarians. Those with a higher degree of independence in daily life had a longer life expectancy after the age of 100 years. The supercentenarians who reached the age of 110 or more had an extremely high degree of independence at the age of 100 years. Supercentenarians also had higher cognitive function (MMSE) at 100–104 years of age than the other 2 groups, and maintenance of cognitive function was significantly associated with independence in ADLs after 100 years of age (Arai et al. 2014). The New England Centenarian Study in the United States tracked the cognitive function of more than 1400 centenarians and showed that the onset of dementia and age-related cognitive decline was slower in centenarians, supercentenarians, and supercentenarians, in that order (Andersen 2012). These studies indicate that supercentenarians are characterized by an extraordinarily long life span with relatively high physical and cognitive functions.
3 Cardiovascular Biomarkers and Exceptional Survival
Aging is a dominant risk factor for most fatal diseases, such as cardiovascular disease, type 2 diabetes mellitus, Alzheimer’s disease, and cancers (Kennedy et al. 2014). Of these, cardiovascular disease is a major cause of death and disability in older adults. We hypothesized that supercentenarians are able to approach the current human longevity limit by preventing or surviving cardiovascular diseases. To test our hypothesis, we examined the cardiometabolic risk factors, electrocardiogram (ECG) results, and a series of circulating biomarkers that reflected distinct cardioprotective and pathogenic pathways in a combined cohort of 1427 oldest individuals including 36 supercentenarians, 572 semi-supercentenarians (105–109 years old), 288 centenarians (100–104 years old), and 531 very old people (85–99 years old) (Hirata et al. 2020). In terms of traditional cardiovascular risk factors, the most striking feature of the centenarians is the low prevalence of diabetes mellitus (Table 3.1). The prevalence of diabetes among centenarians, semi-supercentenarians, and supercentenarians was 7.3%, 5.6%, and 5.6%, respectively, which was less than half of that among the very elderly population aged 85–99 years (18.6%) (Hirata et al. 2020). The prevalence of hypertension (being treated medically or diagnosed) in centenarians was also lower than that in the very old (62.9%) at 38.3%, 44.7%, and 38.9%, respectively. In contrast, centenarians show a relatively high prevalence of moderate-to-severe chronic kidney disease (i.e., stage 3b-5), suggesting that age-related decline in renal function becomes apparent beyond the age of 100 years. Regarding the electrocardiographic characteristics, the major abnormalities such as myocardial infarction, atrial fibrillation, and left ventricular hypertrophy were not common among the centenarian groups (Fig. 3.1 and Table 3.1). The most common ECG findings in supercentenarians were minor abnormalities, such as first-degree atrioventricular block (31.0%) and nonspecific ST-T change (27.6%), followed by left anterior hemiblock (20.7%). Overall, both centenarians and supercentenarians were characterized by low cardiovascular risks including low cholesterol levels and low prevalence of diabetes and left ventricular hypertrophy on ECG.
In our study, we tested nine circulating biomarkers that reflected distinct cardioprotective and pathogenic pathways in relation to mortality as follows: (1) four endogenous cardioprotective molecules [N-terminal pro-B-type natriuretic peptide (NT-proBNP), erythropoietin, adiponectin, and extracellular superoxide dismutase (EC-SOD)]; (2) three inflammatory mediators [interleukin-6, tumor necrosis factor-alpha (TNF-alpha), and angiopoietin-like protein 2 (Angptl2)]; and (3) indicators of the functional reserves of the kidneys and liver [cystatin C and cholinesterase]. As shown in Fig. 3.2, plasma levels of endogenous cardioprotective molecules and inflammatory mediators, except Angptl2, were correlated with ages up to 115 years. Of these, only NT-proBNP showed age-related distributions, with or without a cardiovascular abnormality, supporting this biomarker’s sensitivity for cardiovascular disease up to extreme old age.
Using multivariate Cox hazard models, we identified that high levels of NT-proBNP, interleukin-6, and cystatin C and low levels of cholinesterase and albumin were associated with an increased risk of all-cause mortality in the oldest people. In particular, NT-proBNP was strongly associated with survival beyond 105 years of age. In contrast, plasma albumin, a biomarker of nutrition, was consistently associated with mortality across all age groups.
In a retrospective analysis, where we classified our centenarians into three groups according to age at death (decedent centenarians who died between 100 and 104 years, decedent semi-supercentenarians who died between 105 and 109 years, and decedent supercentenarians who died at 110 years or above), we examined the correlations between the levels of prognostic biomarkers and age at enrollment across the three groups (Fig. 3.3). Only NT-proBNP showed age-specific distributions capable of distinguishing decedent supercentenarians from the younger cohorts (Fig 3.3a). These findings indicate that NT-proBNP levels were significantly lower in decedent supercentenarians than in other decedent centenarians at any given age at assessment. Based on these results, we proposed a working hypothesis that intrinsic aging of the cardiovascular system and possibly the renal system may ultimately deteriorate hemodynamic homeostasis and subsequently limit current human longevity (Fig. 3.4). Supercentenarians, by virtue of a postponed age-related increase in circulating NT-proBNP, may be equipped with efficient mechanisms for delaying the processes of cardiovascular aging. Future studies incorporating detailed assessments of the cardiac structure and functions using ultrasound cardiography are warranted to further validate this hypothesis.
4 Adiponectin
Advancing age is frequently associated with impaired glucose tolerance, insulin resistance, and the development of diabetes, predominantly type 2 diabetes. Nevertheless, several studies have demonstrated that the low prevalence of diabetes and preserved insulin sensitivity are the metabolic peculiarities of centenarians (Paolisso et al. 1996; Wijsman et al. 2011), suggesting that these may have a possible protective factor to maintain insulin sensitivity and glucose homeostasis. To date, vigorous basic research has been conducted on the mechanism underlying the association between insulin sensitivity and longevity. Adiponectin, one of the adipokines secreted from the adipose tissue, has emerged as a possible mechanistic link (Matsuzawa 2006; Rasouli et al. 2008). Adiponectin is an immensely beneficial adipokine (Matsuzawa et al. 2004). It plays an antidiabetic role within the liver and skeletal muscles by facilitating glucose uptake at these sites, thereby enhancing insulin sensitivity. Adiponectin also has anti-inflammatory and anti-atherogenic properties. Several observational studies including our study have shown high plasma adiponectin levels in centenarians (Bik et al. 2006; Arai et al. 2006; Atzmon et al. 2008). These findings support the beneficial metabolic effects of this adipokine.
Interestingly, accumulating observational studies have demonstrated an unexpected association between high adiponectin levels and increased mortality in patients with cardiovascular diseases, particularly those with heart failure (Kistorp et al. 2005). This finding is counterintuitive to its salutary metabolic effects and is referred to as the “adiponectin paradox.” A meta-analysis of 24 prospective studies suggested that the paradoxical association between high adiponectin levels and increased all-cause mortality risk is more significant in those with coronary heart disease (CHD) at the baseline than in those without CHD (Sook Lee et al. 2013). If that is the case, how should we interpret the high adiponectin levels in centenarians? To answer this question, we first examined the correlation between plasma adiponectin levels and cardiometabolic biomarkers in the centenarians. High adiponectin levels were correlated with high levels of high-density lipoprotein (HDL) cholesterol and low levels of HbA1c. This was compatible with this adipokine’s beneficial metabolic effects. High adiponectin levels were also correlated with high levels of EC-SOD, an antioxidant enzyme in extracellular fluids (Sasaki et al. 2021), suggesting potential coordination of the anti-inflammatory and antioxidative pathways. To examine the prognostic significance of adiponectin, we investigated the association between adiponectin and mortality in a combined cohort with 1427 oldest individuals (Hirata et al. 2020). Intriguingly, high adiponectin levels were associated with high mortality in the very old, aged 85–99 years. This finding reflects the “adiponectin paradox.” In contrast, high adiponectin levels were associated with low mortality in centenarians aged 100–104 years but not associated with mortality in semi-supercentenarians aged 105 years or above (Hirata et al. 2020). These results suggest that the association between adiponectin and mortality is complicated in the oldest individuals.
Some aspects of the complicated relationship between adiponectin and health outcomes remain unresolved. Based on the findings so far, we hypothesized that high adiponectin levels in centenarians may reflect the compensatory response to maintain metabolic and redox homeostasis and to counteract oxidative stress and inflammation, which are relevant in catabolic states, such as sarcopenia and chronic heart failure (Arai et al. 2019). Further longitudinal studies with sequential measurements of adiponectin and other biomarkers are warranted to gain a better understanding of the role of adiponectin in promoting healthy aging and longevity.
5 Immunological Biomarkers of Healthy Longevity
Over the past three decades, observational findings have shown that centenarians are relatively immune to illnesses, such as infections and cancers, during their entire lifetime. These findings have led to immunological investigations, one of the most exciting topics in centenarian study. Recently, leukocyte telomere length (LTL), an indicator of senescence in circulating immunological cells, has been recognized as a promising biomarker of aging and age-related diseases (Demanelis et al. 2020). In collaboration with Prof. von Zglinicki of Newcastle University, we measured LTL in 684 centenarians and semi-supercentenarians, 167 pairs of centenarian offspring and their spouses, and 536 community-dwelling very old individuals, aged 85–99 years (Arai et al. 2015). Among the unrelated individuals, LTL shortened with age up to 100 years at rates of 21 ± 8 (males) and 29 ± 4 (females) bp/year. However, after 100 years of age, LTL increased in length by 59 ± 25 (males) and 48 ± 11 (females) bp/year. Interestingly, LTL in centenarian offspring was maintained for more than 20 years at a length corresponding to 60 years of age in the general population. LTL from centenarians and their offspring, and, especially, from semi-supercentenarians, was significantly longer than that expected for their age. LTL was not associated with ADL, cognitive functions, or life expectancy in the centenarians. However, we found that it was correlated with the CD28-positive cell rate, which indicated the extent of aging of the lymphocytes. The higher the CD28-positive cell rate, the longer the life expectancy above 105 years. These results suggest that slow immune senescence may be related to the maintenance of telomere length and longevity in semi-supercentenarians, demonstrating the usefulness of biomarker research in elucidating the mechanisms of healthy longevity.
Single-cell RNA sequencing is a powerful new technology that enables unbiased, high-throughput, and high-resolution transcriptomic analysis of individual cells. Given the importance of cell-to-cell variations, investigation at the single-cell level rather than a group of cells and consideration of the average can provide great insights into the biological process of extreme longevity. Recently, Hashimoto et al. used single-cell RNA analysis to study circulating immune cells from a group of supercentenarians and younger controls. They acquired a total of 41,208 cells from 7 supercentenarians (an average of 5887 per person) and 19,994 cells (an average of 3999 per person) from 5 controls in their 50s to 80s (Hashimoto et al. 2019). They found that while the number of B cells was lower in the supercentenarians, the number of T cells was approximately the same. Moreover, the number of cytotoxic CD4-positive T cells was considerably increased in the supercentenarians. Normally, CD8-positive T cells exert cytotoxic activity, and CD4 T cells do not. As such, the finding suggests that the CD4-positive cells of supercentenarians had acquired cytotoxic status. Hashimoto et al. examined the blood cells of two supercentenarians in detail and found that they had arisen from a process of clonal expansion. Although the pathophysiological roles of CD4 cytotoxic cells in supercentenarians and the clinical implications remain unclear, the study showed how single-cell transcription analysis can contribute to our understanding of immunological pathways associated with healthy longevity.
6 Future Prospects
So far, phenotyping and biomarker studies have shown that slow aging in the cardiovascular, renal, nervous (cognition), and musculoskeletal (ADL) systems is the main characteristic of supercentenarians. There remains a gap between our results and innovations in health promotion and preventive medicine for the general elderly population. In recent years, basic aging research using genetically modified model organisms, such as yeast, nematodes, and mice, has identified evolutionarily conserved signal transduction systems and molecular mechanisms that regulate aging and life span (López-Otín et al. 2013). Elucidation of ultimate aging process of supercentenarians will provide valuable perspectives for developing translational strategies for clinical application of the findings from longevity models. Moreover, multi-omic analyses, such as whole-genome sequencing, transcriptome, and metabolome analyses, are becoming more common. These may replace conventional approach by focusing on the candidate biomarkers that we described in this chapter. The “epigenetic clock” that predicts age by the methylation status of the hundreds of CpG region is a promising biomarker of biological aging (Horvath et al. 2015). Applying multi-omic technology and unraveling the molecular and genetic basis of slow aging in supercentenarians may contribute to the identification of therapeutic targets for the prevention or delay of age-related diseases, particularly cardiovascular diseases, in aging.
References
Andersen SL et al (2012) Health span approximates life span among many supercentenarians: compression of morbidity at the approximate limit of life span. J Gerontol A Biol Sci Med Sci 67:395–405
Arai Y et al (2006) High adiponectin concentration and its role for longevity in female centenarians. Geriatr Gerontol Int 6:32–39. https://doi.org/10.1111/j.1447-0594.2006.00304.x
Arai Y et al (2014) Physical independence and mortality at the extreme limit of life span: supercentenarians study in Japan. J Gerontol A Biol Sci Med Sci 69:486–494
Arai Y et al (2015) Inflammation, but not telomere length, predicts successful ageing at extreme old age: a longitudinal study of semi-supercentenarians. EBioMedicine 2:1549–1558
Arai Y et al (2019) Adipokines and aging: findings from centenarians and the very old. Front Endocrinol 10:142. https://doi.org/10.3389/fendo.2019.00142
Atzmon G et al (2008) Adiponectin levels and genotype: a potential regulator of life span in humans. J Gerontol A Biol Sci Med Sci 63:447–453. https://doi.org/10.1093/gerona/63.5.447
Bik W et al (2006) The relationship between adiponectin levels and metabolic status in centenarian, early elderly, young and obese women. Neuro Endocrinol Lett 27:493–500
Demanelis K et al (2020) Determinants of telomere length across human tissues. Science 369:eaaz6876. https://doi.org/10.1126/science.aaz6876
Gondo Y et al (2006) Functional status of centenarians in Tokyo, Japan: developing better phenotypes of exceptional longevity. J Gerontol A Biol Sci Med Sci 61:305–310
Hashimoto K et al (2019) Single-cell transcriptomics reveals expansion of cytotoxic CD4 T cells in supercentenarians. Proc Natl Acad Sci U S A 116:24242–24251. https://doi.org/10.1073/pnas.1907883116
Hirata T et al (2020) Associations of cardiovascular biomarkers and plasma albumin with exceptional survival to the highest ages. Nat Commun 11:3820
Horvath S et al (2015) Decreased epigenetic age of PBMCs from Italian semi-supercentenarians and their offspring. Aging (Albany NY) 7(12):1159–1170
Kennedy BK et al (2014) Geroscience: linking aging to chronic disease. Cell 159:709–713
Kistorp C et al (2005) Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation 112:1756–1762. https://doi.org/10.1161/CIRCULATIONAHA.104.530972
López-Otín C et al (2013) The hallmarks of aging. Cell 153:1194–1217. https://doi.org/10.1016/j.cell.2013.05.039
Matsuzawa Y et al (2004) Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol 24:29–33. https://doi.org/10.1161/01.ATV.0000099786.99623.EF
Matsuzawa Y (2006) Therapy insight: adipocytokines in metabolic syndrome and related cardiovascular disease. Nat Clin Pract Cardiovasc Med 3:35–42. https://doi.org/10.1038/ncpcardio0380
Paolisso G et al (1996) Glucose tolerance and insulin action in healthy centenarians. Am J Phys 270:890–894
Rasouli N et al (2008) Adipocytokines and the metabolic complications of obesity. J Clin Endocrinol Metab 93(Suppl 1):S64–S73. https://doi.org/10.1210/jc.2008-1613
Sasaki T et al (2021) Association among extracellular superoxide dismutase genotype, plasma concentration, and comorbidity in the very old and centenarians. Sci Rep 11:8539. https://doi.org/10.1038/s41598-021-87982-6
Sook Lee E et al (2013) Association between adiponectin levels and coronary heart disease and mortality: a systematic review and meta-analysis. Int J Epidemiol 42:1029–1039. https://doi.org/10.1093/ije/dyt087
Takayama M et al (2007) Morbidity of Tokyo-area centenarians and its relationship to functional status. J Gerontol A Biol Sci Med Sci 62:774–782
Wijsman CA et al (2011) Familial longevity is marked by enhanced insulin sensitivity. Aging Cell 10:114–121. https://doi.org/10.1111/j.1474-9726.2010.00650.x
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Arai, Y., Hirose, N. (2022). Biomarkers of Healthy Longevity: Lessons from Supercentenarians in Japan. In: Mori, N. (eds) Aging Mechanisms II . Springer, Singapore. https://doi.org/10.1007/978-981-16-7977-3_3
Download citation
DOI: https://doi.org/10.1007/978-981-16-7977-3_3
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-16-7976-6
Online ISBN: 978-981-16-7977-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)